Sage CEO Barry Greene at Endpoints #JPM23 (Adrien Villez for Endpoints News)
February 14, 2024 03:03 PM EST
Pharma

Sage 'en­cour­aged' by ini­tial Zurzu­vae sales in post­par­tum de­pres­sion, but no word on ma­jor de­pres­sion plans

Ryan Cross

Senior Science Correspondent

Doc­tors or­dered 120 pre­scrip­tions of Zurzu­vae, the new pill for post­par­tum de­pres­sion, in the fi­nal days of De­cem­ber once the drug be­came …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times